Dextrose Monohydrate 50% Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dextrose Monohydrate 50% Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 01/13/2022. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-7517-16
- Dosage Form
- Injection
- Presentation
- Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)
- Initial Posting
- 01/13/2022
- Revised Date
Reason
Other